Meeder Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,619
| Closed | -$92K | – | 2566 |
|
|
2021
Q3 | $92K | Buy |
4,619
+2,279
| +97% | +$45.4K | ﹤0.01% | 922 |
|
|
2021
Q2 | $87K | Sell |
2,340
-557
| -19% | -$20.7K | ﹤0.01% | 942 |
|
|
2021
Q1 | $74K | Buy |
+2,897
| New | +$74K | ﹤0.01% | 989 |
|
|
2020
Q4 | – | Sell |
-7,024
| Closed | -$125K | – | 2382 |
|
|
2020
Q3 | $125K | Buy |
+7,024
| New | +$125K | 0.01% | 723 |
|
|
2020
Q2 | – | Sell |
-1,808
| Closed | -$33K | – | 2649 |
|
|
2020
Q1 | $33K | Sell |
1,808
-4,182
| -70% | -$76.3K | ﹤0.01% | 1061 |
|
|
2019
Q4 | $131K | Buy |
+5,990
| New | +$131K | 0.01% | 724 |
|
|
2019
Q3 | – | Sell |
-613
| Closed | -$10K | – | 2320 |
|
|
2019
Q2 | $10K | Hold |
613
| – | – | ﹤0.01% | 1467 |
|
|
2019
Q1 | $9K | Sell |
613
-552
| -47% | -$8.1K | ﹤0.01% | 1283 |
|
|
2018
Q4 | $12K | Buy |
1,165
+90
| +8% | +$927 | ﹤0.01% | 1210 |
|
|
2018
Q3 | $17K | Buy |
+1,075
| New | +$17K | ﹤0.01% | 1071 |
|